Allergan, Inc.
Allergan, Inc. is a global pharmaceutical company that focuses on developing, manufacturing, and commercializing branded pharmaceuticals, devices, and biologic products. The company was originally incorporated in 1948 as Allergan Pharmaceuticals, Inc., and later changed its name to Allergan, Inc. in 1989. It is headquartered in Dublin, Ireland.
History
Allergan, Inc. was founded by pharmacist Gavin S. Herbert and his partner, chemist Stanley Bly, in 1948. The company initially focused on the production of eye drops and contact lens solutions. In the 1950s, Allergan expanded its product line to include ophthalmic products and later diversified into neurology, dermatology, and aesthetics.
Products
Allergan's product portfolio includes leading brands such as Botox, Juvederm, and Restasis. Botox, a botulinum toxin, is used for various therapeutic and aesthetic treatments. Juvederm is a range of dermal fillers used for facial aesthetics. Restasis is an eye drop used to increase tear production in patients with chronic dry eye.
Acquisitions and Mergers
Over the years, Allergan has been involved in several acquisitions and mergers. In 2015, it was acquired by Actavis plc, a global pharmaceutical company, which subsequently adopted the Allergan name. In 2020, Allergan was acquired by AbbVie, a research-based global biopharmaceutical company.
Research and Development
Allergan's research and development efforts are focused on discovering and developing innovative medicines and therapies. The company has a strong pipeline of potential new products in various stages of development, particularly in the areas of eye care, neurology, and aesthetics.
Controversies
Allergan has faced several controversies, including lawsuits related to the safety and marketing of its products. The company has also been criticized for its pricing practices and for its use of a controversial patent protection strategy involving the Saint Regis Mohawk Tribe.
See Also
- Allergan, inc logo.png
Allergan, Inc. Logo
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD